{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:57:44Z","timestamp":1793984264380,"version":"4.8.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T00:00:00Z","timestamp":1544400000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature Chem"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1038\/s41557-018-0187-4","type":"journal-article","created":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T07:20:30Z","timestamp":1543476030000},"page":"254-263","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":116,"title":["Rapamycin-inspired macrocycles with new target specificity"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4370-9445","authenticated-orcid":false,"given":"Zufeng","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam Y.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid","family":"Rehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wukun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanjing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shridhar","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Peiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett R.","family":"Ullman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Ming","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zlatina","family":"Tarmakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cordelia","family":"Schiene-Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunter","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imogen","family":"Coe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3160-7767","authenticated-orcid":false,"given":"Ville O.","family":"Paavilainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoli","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3842-9841","authenticated-orcid":false,"given":"Jun O.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,10]]},"reference":[{"key":"187_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.7164\/antibiotics.28.727","volume":"28","author":"SN Sehgal","year":"1975","unstructured":"Sehgal, S. N., Baker, H. & Vezina, C. Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization. J. Antibiot. 28, 727\u2013732 (1975).","journal-title":"J. Antibiot."},{"key":"187_CR2","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.1021\/ja00250a050","volume":"109","author":"H Tanaka","year":"1987","unstructured":"Tanaka, H. et al. Structure of FK506, a novel immunosuppressant isolated from Streptomyces. J. Am. Chem. Soc. 109, 5031\u20135033 (1987).","journal-title":"J. Am. Chem. Soc."},{"key":"187_CR3","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/341758a0","volume":"341","author":"MW Harding","year":"1989","unstructured":"Harding, M. W., Galat, A., Uehling, D. E. & Schreiber, S. L. A receptor for the immunosuppressant FK506 is a cis\u2013trans peptidyl-prolyl isomerase. Nature 341, 758\u2013760 (1989).","journal-title":"Nature"},{"key":"187_CR4","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/341755a0","volume":"341","author":"JJ Siekierka","year":"1989","unstructured":"Siekierka, J. J., Hung, S. H., Poe, M., Lin, C. S. & Sigal, N. H. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature 341, 755\u2013757 (1989).","journal-title":"Nature"},{"key":"187_CR5","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1126\/science.1715094","volume":"253","author":"J Heitman","year":"1991","unstructured":"Heitman, J., Movva, N. R. & Hall, M. N. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253, 905\u2013909 (1991).","journal-title":"Science"},{"key":"187_CR6","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/0092-8674(91)90124-H","volume":"66","author":"J Liu","year":"1991","unstructured":"Liu, J. et al. Calcineurin is a common target of cyclophilin\u2013cyclosporin A and FKBP\u2013FK506 complexes. Cell 66, 807\u2013815 (1991).","journal-title":"Cell"},{"key":"187_CR7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature12122","volume":"497","author":"H Yang","year":"2013","unstructured":"Yang, H. et al. mTOR kinase structure, mechanism and regulation. Nature 497, 217\u2013223 (2013).","journal-title":"Nature"},{"key":"187_CR8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/0092-8674(95)90439-5","volume":"82","author":"JP Griffith","year":"1995","unstructured":"Griffith, J. P. et al. X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12\u2013FK506 complex. Cell 82, 507\u2013522 (1995).","journal-title":"Cell"},{"key":"187_CR9","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/378641a0","volume":"378","author":"CR Kissinger","year":"1995","unstructured":"Kissinger, C. R. et al. Crystal structures of human calcineurin and the human FKBP12\u2013FK506\u2013calcineurin complex. Nature 378, 641\u2013644 (1995).","journal-title":"Nature"},{"key":"187_CR10","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1073\/pnas.0805375106","volume":"106","author":"PS Marinec","year":"2009","unstructured":"Marinec, P. S. et al. FK506-binding protein (FKBP) partitions a modified HIV protease inhibitor into blood cells and prolongs its lifetime in vivo. Proc. Natl Acad. Sci. USA 106, 1336\u20131341 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"187_CR11","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1146\/annurev.immunol.16.1.569","volume":"16","author":"JD Klemm","year":"1998","unstructured":"Klemm, J. D., Schreiber, S. L. & Crabtree, G. R. Dimerization as a regulatory mechanism in signal transduction. Annu. Rev. Immunol. 16, 569\u2013592 (1998).","journal-title":"Annu. Rev. Immunol."},{"key":"187_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.chembiol.2005.10.017","volume":"13","author":"JH Bayle","year":"2006","unstructured":"Bayle, J. H. et al. Rapamycin analogs with differential binding specificity permit orthogonal control of protein activity. Chem. Biol. 13, 99\u2013107 (2006).","journal-title":"Chem. Biol."},{"key":"187_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1039\/C7MD00474E","volume":"9","author":"SKR Guduru","year":"2018","unstructured":"Guduru, S. K. R. & Arya, P. Synthesis and biological evaluation of rapamycin-derived, next generation small molecules. Med. Chem. Commun. 9, 27\u201343 (2018).","journal-title":"Med. Chem. Commun."},{"key":"187_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/1074-5521(95)90070-5","volume":"2","author":"TK Chakraborty","year":"1995","unstructured":"Chakraborty, T. K., Weber, H. P. & Nicolaou, K. C. Design and synthesis of a rapamycin-based high affinity binding FKBP12 ligand. Chem. Biol. 2, 157\u2013161 (1995).","journal-title":"Chem. Biol."},{"key":"187_CR15","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1021\/co200057n","volume":"13","author":"X Wu","year":"2011","unstructured":"Wu, X. et al. Creating diverse target-binding surfaces on FKBP12: synthesis and evaluation of a rapamycin analogue library. ACS Comb. Sci. 13, 486\u2013495 (2011).","journal-title":"ACS Comb. Sci."},{"key":"187_CR16","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.1016\/j.tetlet.2011.07.094","volume":"52","author":"W Li","year":"2011","unstructured":"Li, W., Bhat, S. & Liu, J. O. A simple and efficient route to the FKBP-binding domain from rapamycin. Tetrahedron Lett. 52, 5070\u20135072 (2011).","journal-title":"Tetrahedron Lett."},{"key":"187_CR17","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1399-3011.1991.tb00765.x","volume":"37","author":"A Furka","year":"1991","unstructured":"Furka, A., Sebestyen, F., Asgedom, M. & Dibo, G. General method for rapid synthesis of multicomponent peptide mixtures. Int. J. Pept. Protein Res. 37, 487\u2013493 (1991).","journal-title":"Int. J. Pept. Protein Res."},{"key":"187_CR18","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/354084a0","volume":"354","author":"RA Houghten","year":"1991","unstructured":"Houghten, R. A. et al. Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery. Nature 354, 84\u201386 (1991).","journal-title":"Nature"},{"key":"187_CR19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/354082a0","volume":"354","author":"KS Lam","year":"1991","unstructured":"Lam, K. S. et al. A new type of synthetic peptide library for identifying ligand-binding activity. Nature 354, 82\u201384 (1991).","journal-title":"Nature"},{"key":"187_CR20","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1002\/(SICI)1521-3773(19991216)38:24<3684::AID-ANIE3684>3.0.CO;2-M","volume":"38","author":"JF Reichwein","year":"1999","unstructured":"Reichwein, J. F., Wels, B., Kruijtzer, J. A., Versluis, C. & Liskamp, R. M. Rolling loop scan: an approach featuring ring-closing metathesis for generating libraries of peptides with molecular shapes mimicking bioactive conformations or local folding of peptides and proteins. Angew. Chem. Int. Ed. 38, 3684\u20133687 (1999).","journal-title":"Angew. Chem. Int. Ed."},{"key":"187_CR21","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1021\/bi00131a002","volume":"31","author":"J Liu","year":"1992","unstructured":"Liu, J. et al. Inhibition of T cell signaling by immunophilin\u2013ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry 31, 3896\u20133901 (1992).","journal-title":"Biochemistry"},{"key":"187_CR22","doi-asserted-by":"publisher","first-page":"9925","DOI":"10.1021\/ja00075a008","volume":"115","author":"DA Halt","year":"1993","unstructured":"Halt, D. A. et al. Design, synthesis and kinetic evaluation of high-affinity FKBP ligands and the X-ray crystal structures of their complexes with FKBP12. J. Am. Chem. Soc. 115, 9925\u20139938 (1993).","journal-title":"J. Am. Chem. Soc."},{"key":"187_CR23","doi-asserted-by":"publisher","first-page":"10437","DOI":"10.1073\/pnas.95.18.10437","volume":"95","author":"T Clackson","year":"1998","unstructured":"Clackson, T. et al. Redesigning an FKBP\u2013ligand interface to generate chemical dimerizers with novel specificity. Proc. Natl Acad. Sci. USA 95, 10437\u201310442 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"187_CR24","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.2174\/0929867043364108","volume":"11","author":"S Sagan","year":"2004","unstructured":"Sagan, S., Karoyan, P., Lequin, O., Chassaing, G. & Lavielle, S. N- and Calpha-methylation in biologically active peptides: synthesis, structural and functional aspects. Curr. Med. Chem. 11, 2799\u20132822 (2004).","journal-title":"Curr. Med. Chem."},{"key":"187_CR25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0022-1759(94)90396-4","volume":"170","author":"SA Ahmed","year":"1994","unstructured":"Ahmed, S. A., Gogal, R. M. Jr & Walsh, J. E. A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. J. Immunol. Methods 170, 211\u2013224 (1994).","journal-title":"J. Immunol. Methods"},{"key":"187_CR26","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.mam.2012.05.007","volume":"34","author":"JD Young","year":"2013","unstructured":"Young, J. D., Yao, S. Y., Baldwin, J. M., Cass, C. E. & Baldwin, S. A. The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29. Mol. Aspects Med. 34, 529\u2013547 (2013).","journal-title":"Mol. Aspects Med."},{"key":"187_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1124\/dmd.105.006270","volume":"34","author":"RP Owen","year":"2006","unstructured":"Owen, R. P. et al. Functional characterization and haplotype analysis of polymorphisms in the human equilibrative nucleoside transporter, ENT2. Drug Metab. Dispos. 34, 12\u201315 (2006).","journal-title":"Drug Metab. Dispos."},{"key":"187_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/15257770.2016.1210805","volume":"36","author":"RC Boswell-Casteel","year":"2017","unstructured":"Boswell-Casteel, R. C. & Hays, F. A. Equilibrative nucleoside transporters\u2014a review. Nucleos. Nucleot. Nucl. 36, 7\u201330 (2017).","journal-title":"Nucleos. Nucleot. Nucl"},{"key":"187_CR29","first-page":"258","volume":"60","author":"JC Xiao","year":"2013","unstructured":"Xiao, J. C., Zhang, T. P. & Zhao, Y. P. Human equilibrative nucleoside transporter 1 (hENT1) predicts the Asian patient response to gemcitabine-based chemotherapy in pancreatic cancer. Hepato-Gastroenterol. 60, 258\u2013262 (2013).","journal-title":"Hepato-Gastroenterol."},{"key":"187_CR30","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1634\/theoncologist.2016-0262","volume":"21","author":"LL Meijer","year":"2016","unstructured":"Meijer, L. L., Puik, J. R., Peters, G. J., Kazemier, G. & Giovannetti, E. hENT-1 Expression and localization predict outcome after adjuvant gemcitabine in resected cholangiocarcinoma patients. Oncologist 21, e4 (2016).","journal-title":"Oncologist"},{"key":"187_CR31","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nrd1983","volume":"5","author":"KA Jacobson","year":"2006","unstructured":"Jacobson, K. A. & Gao, Z. G. Adenosine receptors as therapeutic targets. Nat. Rev. Drug Discov. 5, 247\u2013264 (2006).","journal-title":"Nat. Rev. Drug Discov."},{"key":"187_CR32","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1161\/ATVBAHA.106.126714","volume":"27","author":"M Loffler","year":"2007","unstructured":"Loffler, M., Morote-Garcia, J. C., Eltzschig, S. A., Coe, I. R. & Eltzschig, H. K. Physiological roles of vascular nucleoside transporters. Arterioscler. Thromb. Vasc. Biol. 27, 1004\u20131013 (2007).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"187_CR33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-3-540-89615-9_7","volume":"2009","author":"JP Headrick","year":"2009","unstructured":"Headrick, J. P. & Lasley, R. D. Adenosine receptors and reperfusion injury of the heart. Handb. Exp. Pharmacol. 2009, 189\u2013214 (2009).","journal-title":"Handb. Exp. Pharmacol."},{"key":"187_CR34","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/0006-2952(75)90387-1","volume":"24","author":"CE Cass","year":"1975","unstructured":"Cass, C. E. & Paterson, A. R. Inhibition by nitrobenzylthioinosine of uptake of adenosine, 2\u2032-deoxyadenosine and 9-\u03b2-d-arabinofuranosyladenine by human and mouse erythrocytes. Biochem. Pharmacol. 24, 1989\u20131993 (1975).","journal-title":"Biochem. Pharmacol."},{"key":"187_CR35","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/0304-4165(68)90297-3","volume":"158","author":"C Scholtissek","year":"1968","unstructured":"Scholtissek, C. Studies on the uptake of nucleic acid precursors into cells in tissue culture. Biochim. Biophys. Acta 158, 435\u2013447 (1968).","journal-title":"Biochim. Biophys. Acta"},{"key":"187_CR36","doi-asserted-by":"publisher","first-page":"8375","DOI":"10.1074\/jbc.275.12.8375","volume":"275","author":"JL Ward","year":"2000","unstructured":"Ward, J. L., Sherali, A., Mo, Z. P. & Tse, C. M. Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine. J. Biol. Chem. 275, 8375\u20138381 (2000).","journal-title":"J. Biol. Chem."},{"key":"187_CR37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.pep.2015.07.003","volume":"114","author":"S Rehan","year":"2015","unstructured":"Rehan, S. & Jaakola, V. P. Expression, purification and functional characterization of human equilibrative nucleoside transporter subtype-1 (hENT1) protein from Sf9 insect cells. Protein Expr. Purif. 114, 99\u2013107 (2015).","journal-title":"Protein Expr. Purif."},{"key":"187_CR38","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.bcp.2015.09.019","volume":"98","author":"S Rehan","year":"2015","unstructured":"Rehan, S., Ashok, Y., Nanekar, R. & Jaakola, V. P. Thermodynamics and kinetics of inhibitor binding to human equilibrative nucleoside transporter subtype-1. Biochem. Pharmacol. 98, 681\u2013689 (2015).","journal-title":"Biochem. Pharmacol."},{"key":"187_CR39","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s002100000214","volume":"361","author":"JR Hammond","year":"2000","unstructured":"Hammond, J. R. Interaction of a series of draflazine analogues with equilibrative nucleoside transporters: species differences and transporter subtype selectivity. Naunyn Schmiedebergs Arch. Pharmacol. 361, 373\u2013382 (2000).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"187_CR40","doi-asserted-by":"publisher","first-page":"9231","DOI":"10.1073\/pnas.87.23.9231","volume":"87","author":"BE Bierer","year":"1990","unstructured":"Bierer, B. E. et al. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. Proc. Natl Acad. Sci. USA 87, 9231\u20139235 (1990).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"187_CR41","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1158\/0008-5472.CAN-09-1751","volume":"70","author":"CM Chresta","year":"2010","unstructured":"Chresta, C. M. et al. AZD8055 is a potent, selective and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity. Cancer Res. 70, 288\u2013298 (2010).","journal-title":"Cancer Res."},{"key":"187_CR42","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/337476a0","volume":"337","author":"G Fischer","year":"1989","unstructured":"Fischer, G., Wittmann-Liebold, B., Lang, K., Kiefhaber, T. & Schmid, F. X. Cyclophilin and peptidyl-prolyl cis\u2013trans isomerase are probably identical proteins. Nature 337, 476\u2013478 (1989).","journal-title":"Nature"},{"key":"187_CR43","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.1074\/jbc.M111023200","volume":"277","author":"O Korchynskyi","year":"2002","unstructured":"Korchynskyi, O. & ten Dijke, P. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J. Biol. Chem. 277, 4883\u20134891 (2002).","journal-title":"J. Biol. Chem."},{"key":"187_CR44","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.bbrc.2005.10.024","volume":"338","author":"F Kugimiya","year":"2005","unstructured":"Kugimiya, F. et al. Mechanism of osteogenic induction by FK506 via BMP\/Smad pathways. Biochem. Biophys. Res. Commun. 338, 872\u2013879 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"187_CR45","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1172\/JCI65592","volume":"123","author":"E Spiekerkoetter","year":"2013","unstructured":"Spiekerkoetter, E. et al. FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension. J. Clin. Invest. 123, 3600\u20133613 (2013).","journal-title":"J. Clin. Invest."},{"key":"187_CR46","doi-asserted-by":"publisher","first-page":"F722","DOI":"10.1152\/ajprenal.00378.2004","volume":"288","author":"YJ Day","year":"2005","unstructured":"Day, Y. J., Huang, L., Ye, H., Linden, J. & Okusa, M. D. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages. Am. J. Physiol. Renal Physiol. 288, F722\u2013F731 (2005).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"187_CR47","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1084\/jem.20061097","volume":"203","author":"CM Lappas","year":"2006","unstructured":"Lappas, C. M., Day, Y. J., Marshall, M. A., Engelhard, V. H. & Linden, J. Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. J. Exp. Med. 203, 2639\u20132648 (2006).","journal-title":"J. Exp. Med."},{"key":"187_CR48","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1371\/journal.pmed.0050137","volume":"5","author":"A Grenz","year":"2008","unstructured":"Grenz, A. et al. The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med. 5, e137 (2008).","journal-title":"PLoS Med."},{"key":"187_CR49","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1681\/ASN.2007080901","volume":"19","author":"M Liu","year":"2008","unstructured":"Liu, M. et al. Acute kidney injury leads to inflammation and functional changes in the brain. J. Am. Soc. Nephrol. 19, 1360\u20131370 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"187_CR50","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1021\/jm0310030","volume":"47","author":"L Yan","year":"2004","unstructured":"Yan, L. & Muller, C. E. Preparation, properties, reactions and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugs with peroral bioavailability. J. Med. Chem. 47, 1031\u20131043 (2004).","journal-title":"J. Med. Chem."},{"key":"187_CR51","first-page":"231","volume":"15","author":"T Arai","year":"1962","unstructured":"Arai, T., Kouama, Y., Suenaga, T. & Honda, H. Ascomycin, an antifungal antibiotic. J. Antibiot. 15, 231\u2013232 (1962).","journal-title":"J. Antibiot."},{"key":"187_CR52","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.7164\/antibiotics.41.1592","volume":"41","author":"H Hatanaka","year":"1988","unstructured":"Hatanaka, H. et al. FR-900520 and FR-900523, novel immunosuppressants isolated from a Streptomyces. II. Fermentation, isolation and physico-chemical and biological characteristics. J. Antibiot. 41, 1592\u20131601 (1988).","journal-title":"J. Antibiot."},{"key":"187_CR53","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrd2638","volume":"7","author":"G Hasko","year":"2008","unstructured":"Hasko, G., Linden, J., Cronstein, B. & Pacher, P. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat. Rev. Drug Discov. 7, 759\u2013770 (2008).","journal-title":"Nat. Rev. Drug Discov."},{"key":"187_CR54","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0278-5846(02)00338-X","volume":"27","author":"M Vaswani","year":"2003","unstructured":"Vaswani, M., Linda, F. K. & Ramesh, S. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog. Neuropsychopharmacol. Biol. Psychiatry 27, 85\u2013102 (2003).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"187_CR55","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrd3955","volume":"12","author":"JF Chen","year":"2013","unstructured":"Chen, J. F., Eltzschig, H. K. & Fredholm, B. B. Adenosine receptors as drug targets\u2014what are the challenges? Nat. Rev. Drug Discov. 12, 265\u2013286 (2013).","journal-title":"Nat. Rev. Drug Discov."},{"key":"187_CR56","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante, M. & Sabatini, D. M. mTOR signaling in growth control and disease. Cell 149, 274\u2013293 (2012).","journal-title":"Cell"},{"key":"187_CR57","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.ceb.2011.09.003","volume":"23","author":"E Dazert","year":"2011","unstructured":"Dazert, E. & Hall, M. N. mTOR signaling in disease. Curr. Opin. Cell Biol. 23, 744\u2013755 (2011).","journal-title":"Curr. Opin. Cell Biol."},{"key":"187_CR58","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1600-065X.2008.00756.x","volume":"228","author":"JO Liu","year":"2009","unstructured":"Liu, J. O. Calmodulin-dependent phosphatase, kinases and transcriptional corepressors involved in T-cell activation. Immunol. Rev. 228, 184\u2013198 (2009).","journal-title":"Immunol. Rev."},{"key":"187_CR59","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/0167-5699(92)90111-J","volume":"13","author":"SL Schreiber","year":"1992","unstructured":"Schreiber, S. L. & Crabtree, G. R. The mechanism of action of cyclosporin A and FK506. Immunol. Today 13, 136\u2013142 (1992).","journal-title":"Immunol. Today"},{"key":"187_CR60","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1146\/annurev.immunol.15.1.707","volume":"15","author":"A Rao","year":"1997","unstructured":"Rao, A., Luo, C. & Hogan, P. G. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15, 707\u2013747 (1997).","journal-title":"Annu. Rev. Immunol."}],"container-title":["Nature Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41557-018-0187-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41557-018-0187-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41557-018-0187-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:42:55Z","timestamp":1684604575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41557-018-0187-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,10]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["187"],"URL":"https:\/\/doi.org\/10.1038\/s41557-018-0187-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.32920\/21979724","asserted-by":"object"},{"id-type":"doi","id":"10.32920\/21979724.v1","asserted-by":"object"}]},"ISSN":["1755-4330","1755-4349"],"issn-type":[{"value":"1755-4330","type":"print"},{"value":"1755-4349","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,10]]},"assertion":[{"value":"26 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Patent applications covering the rapafucin library and rapadocin have been filed by Johns Hopkins University and licensed to Rapafusyn Pharmaceuticals, Inc. J.O.L. is a co-founder of, as well as a Scientific Advisory Board Member for, Rapafusyn Pharmaceuticals, Inc. This arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflict of interest policies.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}